About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Related Articles

Articles

Abstract: Right Ventricular Energetic Efficiency Improvement During Left…

Taro Kariya,

Published:

Citation: Interventional Cardiology Review 2021;16(Suppl 2):20–1.

Abstract: Impella RP Versus Pharmacological Vasoactive Treatment in…

Jakob Josiassen,

Published:

Citation: Interventional Cardiology Review 2021;16(Suppl 2):20.

Abstract: Left Ventricular Unloading Protects Against Both Ischaemic and…

Lija Swain,

Published:

Citation: Interventional Cardiology Review 2021;16(Suppl 2):16–7.

ST-segment Elevation MI-Door-to-Unload Trial Updates

Zach George,

Published:

Citation: Interventional Cardiology Review 2021;16(Suppl 2):15–6.